We are live on
!
Find out more
AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
24 hedge funds and large institutions have $26.7M invested in Agile Therapeutics in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less capital invested
Capital invested by funds: $28M → $26.7M (-$1.33M)
8% less funds holding
Funds holding: 26 → 24 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
24
Holders Change
-2
Holders Change %
-7.69%
% of All Funds
0.52%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
5
Reduced
2
Closed
3
Calls
$217K
Puts
–
Net Calls
+$217K
Net Calls Change
-$167K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.37M |
| 2 |
Renaissance Technologies
New York
|
+$168K |
| 3 |
JP Morgan Chase
New York
|
+$101K |
| 4 |
BlackRock
New York
|
+$50.3K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$44.7K |
Top Sellers
| 1 |
PVI
Pura Vida Investments
New York
|
-$112K |
| 2 |
NIM
Needham Investment Management
New York
|
-$89.4K |
| 3 |
VF
Virtu Financial
New York
|
-$88K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$5.58K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$2.79K |
